Aptalis Pharma Canada Inc.
Records under this name other than patents Aptalis Pharma Canada Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Aptalis Pharma Canada Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,541,384 | Mesalamine Suppository Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,217,083 | Mesalamine Suppository Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,884,018 | Mesalamine Suppository Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,087,493 | Method for Detecting Infectious Parvovirus in Pharmaceutical Preparations Formerly held In force · High confidence | In force | High confidence | |
| US 8,436,051 | Mesalamine Suppository Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,618,067 | L-Sugar Colon Cleansing Agent and Uses Thereof Formerly held Lapsed on the fee record Ended Dec 31, 2025 · Medium confidence | Lapsed on the fee record | Ended Dec 31, 2025 | Medium confidence |
| US 6,350,468 | Double capsule for the administration of active principles in multiple therapies Formerly held Term ended Term ended Jun 16, 2020 · From the USPTO record | Term ended | Term ended Jun 16, 2020 | From the USPTO record |
| US 8,470,983 | L-Sugar Colon Cleansing Agent and Uses Thereof Formerly held Lapsed on the fee record Ended Jun 25, 2017 · High confidence | Lapsed on the fee record | Ended Jun 25, 2017 | High confidence |
| US 5,731,302 | Stable aqueous suspensions of mesalazine Term ended Term ended no later than Mar 24, 2018 · Low confidence | Term ended | Term ended no later than Mar 24, 2018 | Low confidence |